Benea, O.E.; Streinu-Cercel, A.; Dorobăț, C.; Rugină, S.; Negruțiu, L.; Cupșa, A.; Duiculescu, D.; Chiriac, C.; Itu, C.; Prisăcariu, L.J.;
et al. Efficacy and Safety of Darunavir (Prezista®) with Low-Dose Ritonavir and Other Antiretroviral Medications in Subtype F HIV-1 Infected, Treatment-Experienced Subjects in Romania: A Post-Authorization, Open-Label, One-Cohort, Non-Interventional, Prospective Study. GERMS 2014, 4, 59-69.
https://doi.org/10.11599/germs.2014.1057
AMA Style
Benea OE, Streinu-Cercel A, Dorobăț C, Rugină S, Negruțiu L, Cupșa A, Duiculescu D, Chiriac C, Itu C, Prisăcariu LJ,
et al. Efficacy and Safety of Darunavir (Prezista®) with Low-Dose Ritonavir and Other Antiretroviral Medications in Subtype F HIV-1 Infected, Treatment-Experienced Subjects in Romania: A Post-Authorization, Open-Label, One-Cohort, Non-Interventional, Prospective Study. GERMS. 2014; 4(3):59-69.
https://doi.org/10.11599/germs.2014.1057
Chicago/Turabian Style
Benea, Otilia Elisabeta, Adrian Streinu-Cercel, Carmen Dorobăț, Sorin Rugină, Lucian Negruțiu, Augustin Cupșa, Dan Duiculescu, Carmen Chiriac, Corina Itu, Liviu Jany Prisăcariu,
and et al. 2014. "Efficacy and Safety of Darunavir (Prezista®) with Low-Dose Ritonavir and Other Antiretroviral Medications in Subtype F HIV-1 Infected, Treatment-Experienced Subjects in Romania: A Post-Authorization, Open-Label, One-Cohort, Non-Interventional, Prospective Study" GERMS 4, no. 3: 59-69.
https://doi.org/10.11599/germs.2014.1057
APA Style
Benea, O. E., Streinu-Cercel, A., Dorobăț, C., Rugină, S., Negruțiu, L., Cupșa, A., Duiculescu, D., Chiriac, C., Itu, C., Prisăcariu, L. J., & Iosif, I.
(2014). Efficacy and Safety of Darunavir (Prezista®) with Low-Dose Ritonavir and Other Antiretroviral Medications in Subtype F HIV-1 Infected, Treatment-Experienced Subjects in Romania: A Post-Authorization, Open-Label, One-Cohort, Non-Interventional, Prospective Study. GERMS, 4(3), 59-69.
https://doi.org/10.11599/germs.2014.1057
